Study Describes Bleeding Risk With Anticoagulants for VTE Study Describes Bleeding Risk With Anticoagulants for VTE

New research may help doctors assess the long-term risk for major bleeding if anticoagulation for unprovoked venous thromboembolism (VTE) is continued beyond 3 –6 months.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Internal Medicine News Source Type: news